Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Incyte Corp (INCY)

Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
KHC
2 Mid-Cap Stocks with Exciting Potential and 1 We Question StockStory - Thu Jan 15, 10:33PM CST

2 Mid-Cap Stocks with Exciting Potential and 1 We Question

CW : 663.84 (+0.48%)
KHC : 23.53 (-2.93%)
INCY : 106.21 (+0.92%)
INCY
Why Incyte (INCY) Stock Is Trading Up Today StockStory - Wed Jan 14, 3:20PM CST

Why Incyte (INCY) Stock Is Trading Up Today

INCY : 106.21 (+0.92%)
Incyte Corp_ office sign-by Bo Shen via iStock
Earnings Preview: What To Expect From Incyte's Report Barchart - Tue Jan 13, 8:03AM CST

Incyte is scheduled to release its fourth-quarter results soon, with analysts projecting double-digit surge in its bottom line figure.

XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)
INCY : 106.21 (+0.92%)
PCTY
2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges StockStory - Wed Jan 7, 10:38PM CST

2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges

INCY : 106.21 (+0.92%)
PCTY : 140.10 (-1.09%)
CLOV : 2.54 (-3.05%)
INCY
Incyte (INCY) Stock Is Up, What You Need To Know StockStory - Wed Jan 7, 10:21AM CST

Incyte (INCY) Stock Is Up, What You Need To Know

INCY : 106.21 (+0.92%)
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma Business Wire - Mon Jan 5, 6:30AM CST

- Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi ® /Minjuvi ® ) and lenalidomide in addition to R-CHOP met its...

INCY : 106.21 (+0.92%)
STRA
2 Safe-and-Steady Stocks Worth Your Attention and 1 Facing Challenges StockStory - Wed Dec 24, 2025

2 Safe-and-Steady Stocks Worth Your Attention and 1 Facing Challenges

MA : 539.49 (-0.58%)
STRA : 83.92 (-0.71%)
INCY : 106.21 (+0.92%)
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma Business Wire - Mon Dec 22, 2025

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide...

INCY : 106.21 (+0.92%)
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer Business Wire - Mon Dec 22, 2025

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based...

INCY : 106.21 (+0.92%)
Incyte to Present at Upcoming Investor Conference Business Wire - Thu Dec 18, 2025

Incyte (Nasdaq:INCY) announced today that it will present at the 44 th Annual J. P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 am (PST). The presentation...

INCY : 106.21 (+0.92%)

Barchart Exclusives

Why Capital Allocation Matters More Than Earnings Right Now Barchart - 58 minutes ago
Earnings explain the past. Capital allocation determines who wins next. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot